NSAC Reporting UFC’s Kevin Casey and Robert Drysdale Failed Post Fight Drug Tests
By FCF Staff
The UFC’s Kevin Casey and Robert Drysdale scored quick victories in their most recent fights, but it looks as though the fighters could see the wins overturned.
According to an announcement from the UFC, the Nevada State Athletic Commission has informed the promotion Drysdale and Casey failed their recent, post-fight drug tests.
Casey took out Bubba Bush with a series of elbows at UFC 175 on July 5th, while Drysdale tapped out Kevin Berish with a rear-naked-choke one night later at the TUF 19 Finale. The UFC relayed on Wednesday:
The UFC has been notified by the Nevada State Athletic Commission that UFC middleweight Kevin Casey and light heavyweight Robert Drysdale failed drug tests following their fights at UFC 175 and The Ultimate Fighter Finale, respectively. Casey tested positive for drostanolone and Drysdale was flagged for an elevated testosterone-to-epitestosterone ratio. Both fighters have been temporarily suspended from competition and informed their positive tests violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC. The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes and will support the NSAC’s determination pending a formal hearing at a later date.
Drysdale, who has applied for a testosterone-replacement-therapy exemption in the past, was flagged by the NSAC in 2013 for having an elevated T/E ratio.
Both Casey and Drysdale were making their UFC debuts.